Table 1. Enrollment characteristics of sample.
| HIV+ | HIV− | |||||
| Men | Women | All HIV+ | Men | Women | All HIV− | |
| Total, n | 126 | 121 | 247 | 168 | 32 | 200 |
| Age, mean (SD), yrs | 52.0 (8.0) | 45.6 (8.6) | 48.9 (8.9) | 56.7 (9.5) | 40.9 (10.2) | 54.2 (11.2) |
| Race, n (%) | ||||||
| Non-black | 58 (46.0) | 26 (21.5) | 84 (34.0) | 134 (79.8) | 9 (28.1) | 143 (71.5) |
| Black | 68 (54.0) | 95 (78.5) | 163 (66.0) | 34 (20.2) | 23 (71.9) | 57 (28.5) |
| Ever AIDS, n (%) | 22 (17.5) | 44 (36.4) | 66 (26.7) | |||
| Ever mono, n (%) | 37 (29.4) | 47 (38.8) | 84 (34.0) | |||
| Ever combo, n (%) | 59 (46.8) | 70 (57.9) | 129 (52.2) | |||
| Ever HAART, n (%) | 116 (92.1) | 99 (81.8) | 215 (87.0) | |||
| Current HAART, n (%) | 105 (83.3) | 85 (70.3) | 190 (76.9) | |||
| Nadir CD4+ T cell count, mean (SD) | 281.5 (174.1) | 258.6 (183.0) | 270.2 (178.5) | |||
| Current CD4+ T cell count, mean (SD) | 568.8 (277.0) | 543.6 (291.7) | 556.4 (284.0) | |||
| Peak CD8+ T cell count, mean (SD) | 1468.8 (699.8) | 1371.7 (656.5) | 1421.3 (679.3) | |||
| Current CD8+ T count, mean (SD) | 910.2 (403.4) | 805.4 (361.9) | 858.8 (386.4) | |||
| Undetectable HIV RNA, n (%) | 99 (78.6) | 60 (49.6) | 159 (64.4) | |||
| Log10 HIV RNA, median (IQR) | 3.94 (2.91, 4.45) | 3.44 (2.67, 4.40) | 3.50 (2.68, 4.42) | |||
Ever AIDS, ever diagnosed with AIDS; Ever mono, ever used monotherapy; Ever combo, ever used combination HAART and monotherapy; Ever HAART, ever used HAART. Undetectable HIV RNA, subjects with undetectable levels of HIV RNA; Log10 HIV RNA, log level of HIV RNA among HIV+ participants with detectable levels of RNA (n = 27 men and 61 women).